Financial News
Marinus Pharma CS (NQ: MRNS )
1.440
+0.010
(+0.71%)
Streaming Delayed Price
Updated: 11:43 AM EDT, Jul 22, 2024
Add to My Watchlist
All News about Marinus Pharma CS
![](https://mms.businesswire.com/media/20230727626834/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230713697795/en/1638593/5/marinus-color.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/options_image_0.jpeg?width=1200&height=800&fit=crop)
10 Health Care Stocks Whale Activity In Today's Session
June 29, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Analyst Expectations for Marinus Pharma's Future
June 23, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
The Latest Analyst Ratings for Marinus Pharma
May 30, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Marinus Pharma: Q1 Earnings Insights
May 11, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Where Marinus Pharma Stands With Analysts
April 25, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230621023451/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230602005299/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230525005802/en/1638593/5/marinus-color.jpg)
![](/next-assets/images/schema-image-default.png)
![](https://mms.businesswire.com/media/20230517005563/en/1638593/5/marinus-color.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/12/heron_therapeutics_-_logo_copy.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
6 Analysts Have This to Say About Marinus Pharma
March 08, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Marinus Pharmaceuticals
March 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/20/mrns.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230511005063/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230509005832/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230503005050/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230427005079/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230418005114/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230406005640/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230322005508/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230307005068/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230306005761/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230207005156/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230210005013/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230207005159/en/1638593/5/marinus-color.jpg)
Marinus Pharmaceuticals to Present at Upcoming Investor Conferences
February 07, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230130005041/en/1638593/5/marinus-color.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2108.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2023
January 20, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.